Reshape Biotech Secures $20M in Series A Funding for Groundbreaking Lab Automation Robots - Paving the Way for Biotech Innovation

Reshape Biotech is thrilled to announce the successful raising of $20 million in our latest funding round, a significant milestone that will accelerate our mission to revolutionize lab automation for biotech companies addressing some of the world’s most pressing challenges, such as alternative protein development and sustainable agriculture. With this substantial investment, we aim to enhance our innovative robotics solutions that empower researchers to collaborate globally and dramatically increase their experimental throughput by over 500 times. As we stand at the forefront of a transformative wave in the biotech industry, our team, comprised of PhDs in biology, seasoned hardware and software engineers, and industry veterans, is uniquely positioned to drive this change. The funds will be allocated toward expanding our R&D capabilities, optimizing our cutting-edge automation technology, and scaling our operations to meet the growing demand from our esteemed clientele, which includes global leaders in food, agriculture, and biologicals. We are immensely proud to have the backing of top-tier investors from Y Combinator, influential CEOs, and key figures in the industry, which not only validates our vision but also propels us toward setting a new standard for biotech infrastructure. As we continue to develop solutions that make biotech research more efficient and impactful, we invite you to join us on this groundbreaking journey toward shaping the future of science and innovation for the next century.